POLYMER SYSTEM AND METHOD FOR ENCAPSULATING HUMAN AMYLIN AND AGONIST ANALOGUES, AND USE THEREOF; RELEASED AMYLIN FUNCTIONAL EVALUATION METHOD
    36.
    发明申请
    POLYMER SYSTEM AND METHOD FOR ENCAPSULATING HUMAN AMYLIN AND AGONIST ANALOGUES, AND USE THEREOF; RELEASED AMYLIN FUNCTIONAL EVALUATION METHOD 审中-公开
    聚合物体系和方法,用于包埋人类AMYLIN和激动剂类似物,及其用途; 释放的AMYLIN功能评估方法

    公开(公告)号:WO2012031342A2

    公开(公告)日:2012-03-15

    申请号:PCT/BR2011000316

    申请日:2011-09-08

    IPC分类号: A61K38/22

    CPC分类号: A61K38/22

    摘要: Diabetes mellitus is a disease which, according to the World Health Organisation, is responsible for a significant proportion of deaths throughout the world. In spite of the large number of glycemic control products aimed at diabetes, there still exist pharmacological and pharmacokinetic gaps to be filled. The present invention aims at describing a method for developing a polymer system for encapsulating amylin and agonist analogues in the form of nanoparticles and microparticles. Another object of the invention is a method of functional in vitro evaluation of amylin released from polymer encapsulation systems. The invention further describes the use of the system for producing a medicament for amylin replenishment therapy in patients, which can be used for treating or preventing metabolic diseases.

    摘要翻译: 根据世界卫生组织的统计,糖尿病是一种疾病,在世界各地造成很大比例的死亡。 尽管针对糖尿病的大量血糖控制产品仍然存在药物和药代动力学缺口。 本发明的目的在于描述一种开发用于将胰岛淀粉样多肽和激动剂类似物包封成纳米颗粒和微粒形式的聚合物体系的方法。 本发明的另一个目的是从聚合物封装系统释放的胰岛淀粉样多肽的功能性体外评估方法。 本发明还描述了该系统用于生产可用于治疗或预防代谢性疾病的患者中的胰岛淀粉样多肽补充治疗药物的用途。